NCT05945563View on ClinicalTrials.gov

Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms

RecruitingOBSERVATIONAL

Enrollment

208

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

January 17, 2025

Study Completion Date

December 17, 2025

Conditions

Cerebral Aneurysm

Trial Locations (1)

75203

RECRUITING

Methodist Dallas Medical Center, Dallas

All Listed Sponsors

lead

Methodist Health System

OTHER

NCT05945563 - Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms | Biotech Hunter | Biotech Hunter